Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0101117 Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency
The present invention relates to improving the heart function, the survival and/or the treatment of heart insufficiency using megestrol acetate (Megace.RTM.;...
2016/0101116 ESTROGENIC COMPONENTS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
The invention relates to the prophylactic and therapeutic applications of certain estrogenic components, such as estetrol in neurological disorders, such as...
2016/0101115 METHODS OF TREATING ERECTILE DYSFUNCTION
An active agent for use in a method of, or for use in the preparation of a medicament for, treating or inhibiting the development of erectile dysfunction...
2016/0101114 ARTICLES AND METHODS FOR PREVENTING AND TREATING DERMATOLOGIC ADVERSE EVENTS
The present invention provides articles and methods for preventing or treating dermatologic adverse events.
2016/0101113 AGENT FOR PROMOTING CORNEAL ENDOTHELIAL CELL ADHESION
The invention provides an agent for promoting adhesion of a corneal endothelial cell, containing a Rho kinase inhibitor, as well as a culture medium for a...
2016/0101112 PHARMACEUTICAL COMPOSITION COMPRISING N1-CYCLIC AMINE-N5-SUBSTITUTED BIGUANIDE DERIVATIVES AS AN INGREDIENT FOR...
The present invention provides a novel use of N1-cyclic amine-N5-substituted biguanide derivatives for preparing a medicine for preventing or treating...
2016/0101111 COMBINED INHIBITION OF THE VITAMIN D RECEPTOR AND POLY(ADP) RIBOSE POLYMERASE (PARP) IN THE TREATMENT OF CANCER
Methods for treating tumors comprise contacting tumor cells expressing the vitamin D receptor with a vitamin D receptor ligand that inhibits homologous...
2016/0101110 Novel Formulation of Meloxicam
Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties...
2016/0101109 METHOD OF TREATING ARTHRITIS
Methods of preventing or treating arthritis is disclosed.
2016/0101108 PRINTED DOSAGE FORMS
The present invention relates to oral dosage forms of vitamin(s) and/or dietary mineral(s) or nicotine produced by printing techniques. The present invention...
2016/0101107 COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR...
An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases...
2016/0101106 METHODS FOR TREATING HCV INFECTION
The present invention provides methods of treating HCV infection in subjects (e.g., mammals), comprising administering to a subject in need thereof an...
2016/0101105 HIGH DRUG LOAD TABLET
The present invention pertains to a high drug load tablet comprising as active ingredient Compound I of formula ##STR00001## or a pharmaceutically acceptable...
2016/0101104 QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands...
2016/0101103 METHOD FOR THE PRODUCTION OF A MEDICAMENT CONTAINING TADALAFIL
The invention relates to a method for producing a medicament containing tadalafil. In said method, tadalafil is mixed with suitable adjuvants and is heated to...
2016/0101102 PIPERAZINE THIAZOLE DERIVATIVES USEFUL IN THE TREATMENT OF TAUOPATHIES SUCH AS ALZHEIMER'S DISEASE
The present invention relates to a compound of formula (IA), wherein G.sup.1 is lower alkyl; lower alkyl substituted by one or more halogens; cycloalkyl;...
2016/0101101 SUBLINGUAL APOMORPHINE
The invention features sublingual formulations of apomorphine and apomorphine prodrugs, and methods of treating Parkinson's disease, sexual dysfunction, and...
2016/0101100 TRANSDERMAL DELIVERY SYSTEM
The invention relates to transdermal therapeutic system for the transdermal administration of buprenorphine, comprising a buprenorphine-containing...
2016/0101099 H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-te- trahydroisoquinoline-7-sulfonamide in a...
2016/0101098 SMALL MOLECULE ACTIVATORS OF NRF2 PATHWAY
This disclosure relates to compounds that act as activators of the NRF2/KEAP1/ARE pathway. Specifically, the compounds provided herein can act as high affinity...
2016/0101097 Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
A medicament comprising, separately or together (A) glycopyrrolate; and (B) either a compound of formula I ##STR00001## in free or salt or solvate form, wherein W,...
2016/0101096 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF
Amino, amido, and heterocyclic compounds are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and...
2016/0101095 TREATMENT FOR CEREBRAL PALSY GAIT IMPAIRMENT
A methylphenidate, particularly including dextro-threo-methylphenidate, is administered to a child to treat a gait impairment and a speech impairment secondary...
2016/0101094 ASSAYS, METHODS AND MEANS
A novel class of hydroxylases is described having the amino acid sequence of SEQ ID NO: 2, 4, 6 and 8, and variants and fragments thereof having HIF...
2016/0101093 METHODS FOR THE TREATMENT OF PREMATURE EJACULATION
The invention relates to methods of treating premature ejaculation in a patient in need thereof, wherein the methods comprise administering an effective amount...
2016/0101092 1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF
Provided herein are compounds according to Formula I and pharmaceutically acceptable salts thereof, and compositions comprising the same, for use in various...
2016/0101091 ALKYLAMINE DERIVATIVE
A composition containing a compound represented by General Formula (I) below (see the definition in the specification for the symbols in the formula) or a salt...
2016/0101090 INHIBITION OF TRK KINASE MEDIATED TUMOR GROWTH AND DISEASE PROGRESSION
It has been shown that Compound 1 unexpectedly and potently inhibits TRK kinases, including all three forms of TRK: NTRK1, NTRK2, and NTRK3. Additionally it...
2016/0101089 NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is...
2016/0101088 COMPOSITION INCLUDING RAPAMYCIN AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING HEARING LOSS
A pharmaceutical or health food includes rapamycin as an active ingredient, the pharmaceutical or health food being applied for prevention, improvement, and...
2016/0101087 METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY
The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases...
2016/0101086 METHODS OF TREATING MUSCULAR DYSTROPHY
Disclosed herein are methods of improving muscular health, such as enhancing muscle regeneration, maintenance, or repair. In some examples, the method includes...
2016/0101085 METHODS OF ADMINISTERING DANTROLENE FOR THE ACUTE TREATMENT OF CARDIAC ARRHYTHMIAS
The present description relates to methods of administering effective amounts of an anti-arrhythmic agent, e.g., dantrolene, azumolene or a pharmaceutically...
2016/0101084 METHODS OF TREATING DEGENERATIVE DISEASES/INJURIES
Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a...
2016/0101083 ANTI-PARASITIC METHODS AND COMPOSITIONS UTILIZING DIINDOLYLMETHANE-RELATED INDOLES
The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related...
2016/0101082 PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR THE TREATMENT OF CANCER
Provided is a novel medicament capable of reducing the side effects of metformin or a pharmaceutically acceptable salt thereof and useful as an anti-malignant...
2016/0101081 COMPOSITIONS AND METHODS FOR ENHANCING MOBILITY OR ACTIVITY OR TREATING FRAILTY
The present invention provides a method for increasing mobility or activity in an animal or treating or preventing frailty in an animal, comprising identifying...
2016/0101080 ASSAYS, METHODS AND MEANS
A novel class of hydroxylases is described having the amino acid sequence of SEQ ID NO: 2, 4, 6 and 8, and variants and fragments thereof having HIF...
2016/0101079 PROTECTIVE METALLOTHIONEIN ANALOG COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PATHOGENIC...
Embodiments of the present invention relate generally the use of certain compositions, e.g., compositions comprising a glutathione precursor and a selenium...
2016/0101078 COMPOSITIONS COMPRISING AMINO ACIDS FOR USE IN THE TREATMENT OF STROKE IN PATIENTS WITH DYSPHAGIA
Composition for use in the treatment of stroke, particularly in patients with dysphagia, the composition comprising an active agent, said active agent...
2016/0101077 Compositions and Methods for Treating Severe Pain
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a...
2016/0101076 Use of Sumoylation Inhibitors for Treating Cancer
The present invention provides methods and reagents for treating cancer cells for therapeutic purposes, by contacting with a sumoylation inhibitor in a dose...
2016/0101075 ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally...
2016/0101074 SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
The present invention provides sulfamoylbenzamide derivatives, and pharmaceutical compositions thereof. In certain embodiments, the compounds and...
2016/0101073 COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHROD OF MAKING AND USE THEREOF
Pharmaceutical compositions for reducing frequency of urination are disclosed. The pharmaceutical compositions comprise one or more prostaglandin pathway...
2016/0101072 Therapeutic uses of enzyme inhibitors
The invention relates to use of compounds which inhibit VAP-1/SSAO activity for the treatment of muscular dystrophy. The invention also relates to combined...
2016/0101071 COMBINATION CANCER TREATMENT
Described herein is TRAIL receptor targeting therapy in combination with metformin for treatment of cancer in humans. Using TRAIL receptor targeting therapy...
2016/0101070 COMPOSITION COMPRISING ASM INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DEGENERATIVE NEUROLOGICAL...
The present invention relates to a composition comprising an ASM inhibitor as an active ingredient for preventing or treating degenerative neurological...
2016/0101069 METHOD FOR TREATING POST-TRAUMATIC STRESS DISORDER
The present disclosure provides compositions containing ketamine and methods of using those compositions for the treatment of post-traumatic stress disorder....
2016/0101068 Anti-Cancer Cycloalkyl Diamines
The invention is directed to a method of treatment of a cancer, in a mammal, the method comprising administering to said mammal in need of such treatment an...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.